figshare
Browse

Embargoed and Restricted Access

Reason: Under embargo until May 2019. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library

Models of care for hepatitis C in the era of direct acting antiviral therapy

thesis
posted on 2018-05-08, 01:15 authored by AMANDA JANE WADE
In 2014, only 1% of Australians with hepatitis C had received treatment. Low treatment rates mean that hepatitis C is a leading cause of liver cancer and liver failure. New, highly effective direct acting antiviral (DAA) treatment for hepatitis C virus infection became available in Australia in March 2016. Australia is now in the position to eliminate HCV. Key is to increase access to treatment. This thesis investigates the feasibility and effectiveness of providing hepatitis C treatment in the community.

History

Principal supervisor

Margaret Elena

Additional supervisor 1

Joseph Samuel Doyle

Additional supervisor 2

Alexander Thompson

Year of Award

2018

Department, School or Centre

Public Health and Preventive Medicine

Additional Institution or Organisation

Burnet Institute

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Faculty

Faculty of Medicine Nursing and Health Sciences

Usage metrics

    Faculty of Medicine, Nursing and Health Sciences Theses

    Categories

    Keywords

    Hepatitis Cdirect acting antiviralsmodels of carePublic Health and Health Services not elsewhere classified

    Licence

    In Copyright

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC